# Flindr Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/flindr-therapeutics-b-v

- Industry: Biotechnology
- Headquarters: Netherlands
- Website: www.flindrtx.com
- Total disclosed funding: $21M
- Latest round: Series A (Apr 24, 2024)
- Investors on record: 8

## About

Based in the Netherlands, and founded in 2020, Flindr Therapeutics B.V., formerly known as Immagene, operates as a precision oncology therapeutics company. The firm is spun out of the Netherlands Cancer Institute (NKI) and Oncode Institute and was founded by Maarten Ligtenberg (CEO), Daniel Peeper, and Christian Blank. In April 2024, Flindr Therapeutics raised USD 20 million in Series A funding led by V-Bio Ventures, Johnson & Johnson Innovation, QBIC Fund, Flanders Future Tech Fund, and Curie Capital.

Flindr Therapeutics develops first-in-class small-molecule inhibitors that can be used for the treatment of cancer. The company focuses on developing drugs to treat patients with specific genetic alterations. The firm’s product line includes an ImmunoGram drug discovery engine that develops small-molecule inhibitors of RNF31 (also known as HOIP), which is a protein-stabilizing E3 ubiquitin ligase.

The company will use the funding to progress its lead program and broaden its pipeline using the ImmunoGram drug discovery engine.

## Funding rounds

- Series A, Apr 24, 2024, $21M — Johnson & Johnson Innovation, Qbic Fund, V-Bio Ventures, Brabantse Ontwikkelings Maatschappij, Curie Capital, Swanbridge Capital, Flanders Future Techfund, Oncode Institute
- Seed, Dec 1, 2021 — Brabantse Ontwikkelings Maatschappij, Swanbridge Capital, Oncode Institute

## Investors

- Brabantse Ontwikkelings Maatschappij — Seed, Series A
- Swanbridge Capital (https://capitalatlas.ai/funds/swanbridge-capital) — Seed, Series A
- Oncode Institute — Seed, Series A
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series A
- Qbic Fund (https://capitalatlas.ai/funds/qbic-fund) — Series A
- V-Bio Ventures (https://capitalatlas.ai/funds/v-bio-ventures) — Series A
- Curie Capital (https://capitalatlas.ai/funds/curie-capital) — Series A
- Flanders Future Techfund — Series A